Safety and Pharmacokinetics of Atezolizumab Combination Treatments in Participants With HER2-Positive and HER2-Negative Breast Cancer

Clinical trial NCT02605915 · COMPLETED

Trial details

NCT number: NCT02605915
Sponsor: Hoffmann-La Roche
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

HER2-Positive Metastatic Breast Cancer HER2-Negative Metastatic Breast Cancer Locally Advanced or Early Breast Cancer

Start date: 2015-12-31
Primary completion: 2019-11-13
Enrollment: 98

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.